Gema Santamaría-Núñez (Gema Santamaría Nuñez)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Structure Activity Relationship

Polycyclic Aromatic Hydrocarbons

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia G Cruz, Rogelio Fernández, Raquel Rodríguez-Acebes, Marta Martínez Diez, Gema Santamaría-Núñez, Marta Pérez, Carmen Cuevas
From Sea Sponge to Clinical Trials: Starting the Journey of the Novel Compound PM742. Marine drugs 22 (8) (2024)
Patricia G Cruz, Rogelio Fernández, Raquel Rodríguez-Acebes, Marta Martínez Diez, Gema Santamaría-Núñez, Marta Pérez, Carmen Cuevas
From Sea Sponge to Clinical Trials: Starting the Journey of the Novel Compound PM742. Marine drugs 22 (8) (2024)
Patricia G Cruz, Rogelio Fernández, Raquel Rodríguez-Acebes, Marta Martínez Diez, Gema Santamaría-Núñez, Marta Pérez, Carmen Cuevas
From Sea Sponge to Clinical Trials: Starting the Journey of the Novel Compound PM742. Marine drugs 22 (8) (2024)
Federico Costanzo, Marta Martínez Diez, Gema Santamaría-Núñez, Juan Ignacio Díaz-Hernandéz, Carlos Mario Genes Robles, Javier Díez Pérez, Emmanuel Compe, Romeo Ricci, Tsai-Kun Li, Frederic Coin, Juan Fernando Martínez-Leal, Eva Maria Garrido-Martin, Jean Marc Egly
Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells. EMBO molecular medicine 14 (4) (2022)